With Shire PLC management finally recommending a $62.4bn offer from Takeda Pharmaceutical Co. Ltd., the Japanese pharma is poised to move into the top 10 pharmaceutical companies club.
The combined company will have roughly $30bn in revenues, based on 2017 sales, leapfrogging Takeda into the top pharma rankings...